Results 21 to 30 of about 3,513 (158)

Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study

Frontiers in Pharmacology, 2023
Importance: Checkpoint inhibitor pneumonitis (CIP) is a rare but serious adverse event that may impact treatment decisions. However, there is limited information comparing CIP risks between immune checkpoint inhibitor (ICI) monotherapy and combination ...
Huixia Li, Yifan Zheng, Peihang Xu, Zimu Li, Yukun Kuang, Xiaoqing Feng, Junhao He, Jia Li, Xiao Chen, Lihong Bai, Ke-Jing Tang, Ke-Jing Tang   +11 more
doaj   +1 more source

Suspected cutaneous adverse drug reactions reported with traditional medicines: analysis of data for United Nations Asia region from WHO VigiBase

Frontiers in Pharmacology, 2023
Background: Data on traditional medicine-induced cutaneous adverse drug reactions (ADRs) is very scarce. The current secondary analysis based on the WHO database (VigiBase) of individual case safety reports (ICSRs) focuses on the suspected cutaneous ADRs
Manish J. Barvaliya, A. C. Chetan, N. Chandan, Suman Kumar Ray, Harsha V. Hegde, Banappa S. Unger, Tejas K. Patel, Subarna Roy   +7 more
doaj   +1 more source

Safety of COVID-19 vaccines

Безопасность и риск фармакотерапии, 2022
By June 1, 2022, there were 38 prophylactic COVID-19 vaccines approved in 197 countries around the world. The ongoing approval of new vaccines and the accumulation of more than a year's worth of data on their use give particular importance to the ...
B. K. Romanov
doaj   +1 more source

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19

Регуляторные исследования и экспертиза лекарственных средств, 2020
The review compares individual case safety reports (ICSRs) for hydroxychloroquine, favipiravir, and the lopinavir/ ritonavir combination registered in the VigiBase global database during 6 months in 2019 and the same period in 2020 which coincides with ...
B. K. Romanov
doaj   +1 more source

Major Aspects of Detection and Monitoring of Adverse Reactions Associated with Cephalosporin Antibiotic Treatment

Безопасность и риск фармакотерапии, 2021
Widespread use of cephalosporin antibiotics in clinical practice calls for greater attention to the risk of adverse drug reactions. Information on serious or unexpected adverse events reported during post-marketing experience is submitted to national and
E. Yu. Demchenkova, G. I. Gorodetskaya, I. A. Mazerkina, M. V. Zhuravleva, A. S. Kazakov, M. V. Gorodetskiy, L. Yu. Badriddinova, S. Yu. Serebrova   +7 more
doaj   +1 more source

Signal Detection in EUROmediCAT: Identification and Evaluation of Medication–Congenital Anomaly Associations and Use of VigiBase as a Complementary Source of Reference [PDF]

, 2021
Introduction Knowledge on the safety of medication use during pregnancy is often sparse. Pregnant women are generally excluded from clinical trials, and there is a dependence on post-marketing surveillance to identify teratogenic medications.
Addor, Marie-Claude, Addor, M-C, Materna-Kiryluk, A., Cavadino, A., Materna-Kiryluk, A, Garne, Ester,, Bergvall, T., Ohman, Inger, Star, K., O'Mahony, M., Dolk, H, Öhman, I., Lelong, Nathalie, Klungsøyr, Kari, Cavero-Carbonell, C, Mokoroa, Olatz, Dolk, H., Peirini, A, Barisic, Ingeborg, Nelen, Vera,, Latos-Bielenska, Anna,, Materna-Kiryluk, Anna, Sandberg, L, Cavadino, Alana, Sandberg, Lovisa,, O'Mahony, Mary,, Dolk, Helen,, Yevtushok, Lyubov,, Lelong, N., Star, Kristina,, Loane, M., Yevtushok, Lyubov, Nevill, Amanda,, Khoshnood, B., Bergvall, Tomas, Klungsoyr, Kari, Rissmann, Anke, Mokoroa, Olatz,, Loane, Maria,, Bergvall, Tomas,, Lutke, R., Khoshnood, B, Lelong, N, Wiesel, A, Cavadino, A, Nelen, Vera, Garne, Ester, Wiesel, A., Nevill, A, Cavadino, Alana,, Wiesel, Awi,, Yevtushok, L, O’Mahony, Mary, Star, Kristina, Randrianaivo, Hanitra,, Morris, Joan K.,, Tucker, David,, Tucker, D., Barisic, I, Loane, Maria, Addor, M.C., Star, K, Khoshnood, Babak,, Loane, M, Randrianaivo, H, Randrianaivo, Hanitra, Materna-Kiryluk, Anna,, Barisic, I., Morris, J.K., Cavero-Carbonell, Clara, Latos-Bielenska, Anna, Nevill, Amanda, Lutke, Renee, Tucker, D, Addor, Marie Claude, Nevill, A., Latos-Bielenska, A., Pierini, Anna, Gatt, Miriam,, Nelen, V., Rissmann, A., Cavero-Carbonell, Clara,, Mokoroa, O., Lutke, R, Addor, Marie-Claude,, Khoshnood, Babak, Rissmann, A, Cavero-Carbonell, C., Klungsøyr, K., Klungsoyr, Kari,, Nelen, V, Mokoroa, O, Rissmann, Anke,, Lutke, Renee,, Yevtushok, L., Öhman, I, Garne, E., Pierini, A., Morris, JK, Barisic, Ingeborg,, Pierini, Anna,, Lelong, Nathalie,, Latos-Bielenska, A, Ohman, Inger,, Sandberg, Lovisa, Tucker, David, Dolk, Helen, Gatt, Miriam, O'Mahony, Mary, Wiesel, Awi, Morris, Joan K., Gatt, M, Sandberg, L., Randrianaivo, H., Bergvall, T, Gatt, M., Garne, E, Klungsøyr, K, O'Mahony, M   +118 more
core   +4 more sources

Paracetamol safety in COVID-19

Реальная клиническая практика: данные и доказательства, 2021
The relevance of paracetamol safety assessment is associated with broad recommendations for its use as a symptomatic agent in COVID-19 and an agent for adverse events following vaccination to prevent COVID-19.Objectives.
B. K. Romanov
doaj   +1 more source

Suspected adverse reactions reported for blood, blood components, and blood products in VigiBase [PDF]

, 2023
Introduction: Since being designated as medicines by World Health Organization (WHO), blood components are subject to pharmacovigilance reporting. Using VigiBase, the WHO global database of individual case safety reports (ICSRs), we characterized reports
Souverein, Patrick C., Mantel-Teeuwisse, Aukje K., Lu, Ting An, Samukange, Washington T., Gardarsdottir, Helga   +4 more
core   +2 more sources

Exfoliative dermatitis; new safety signal detection regarding Meropenem in VigiBase™: A study based on WHO database

, 2023
Exfoliative dermatitis; new safety signal detection regarding Meropenem in VigiBase™: A study based on WHO ...
Ahmed Sami
core   +2 more sources

Number of medication error reports submitted by African countries to VigiBase, 1997–2018.

, 2022
Number of medication error reports submitted by African countries to VigiBase, 1997–2018.
Seth Kwaku Seaneke (12191449), Florence van Hunsel (6794741), Mahama Duwiejua (12191452), Eugène van Puijenbroek (6794747), George Tsey Sabblah (12191446), Katja Taxis (797682), Mawuli Kushitor (7402385)   +6 more
core   +1 more source